Labels: A Celebrity Patient's Backing Turns Sour for Drug Company, Andrew Gilman, Bristol-Myers Squibb Co, CommCore, media training, spokesperson, Wall Street Journal
posted by Andrew Gilman, CEO & President at 4:02 PM 1 Comments